224 related articles for article (PubMed ID: 22279212)
1. Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology.
Abramowski D; Rabe S; Upadhaya AR; Reichwald J; Danner S; Staab D; Capetillo-Zarate E; Yamaguchi H; Saido TC; Wiederhold KH; Thal DR; Staufenbiel M
J Neurosci; 2012 Jan; 32(4):1273-83. PubMed ID: 22279212
[TBL] [Abstract][Full Text] [Related]
2. The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice.
Rijal Upadhaya A; Scheibe F; Kosterin I; Abramowski D; Gerth J; Kumar S; Liebau S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
Acta Neuropathol Commun; 2013 Nov; 1(1):77. PubMed ID: 24252227
[TBL] [Abstract][Full Text] [Related]
3. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
5. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
Winton MJ; Lee EB; Sun E; Wong MM; Leight S; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2011 May; 31(21):7691-9. PubMed ID: 21613482
[TBL] [Abstract][Full Text] [Related]
6. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
8. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
9. Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model.
Wirths O; Breyhan H; Cynis H; Schilling S; Demuth HU; Bayer TA
Acta Neuropathol; 2009 Oct; 118(4):487-96. PubMed ID: 19547991
[TBL] [Abstract][Full Text] [Related]
10. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.
Crowther DC; Kinghorn KJ; Miranda E; Page R; Curry JA; Duthie FA; Gubb DC; Lomas DA
Neuroscience; 2005; 132(1):123-35. PubMed ID: 15780472
[TBL] [Abstract][Full Text] [Related]
11. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.
Casas C; Sergeant N; Itier JM; Blanchard V; Wirths O; van der Kolk N; Vingtdeux V; van de Steeg E; Ret G; Canton T; Drobecq H; Clark A; Bonici B; Delacourte A; Benavides J; Schmitz C; Tremp G; Bayer TA; Benoit P; Pradier L
Am J Pathol; 2004 Oct; 165(4):1289-300. PubMed ID: 15466394
[TBL] [Abstract][Full Text] [Related]
12. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
Christensen DZ; Bayer TA; Wirths O
Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817
[TBL] [Abstract][Full Text] [Related]
13. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
14. No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the beta-cleaved C-terminal APP fragment.
Rutten BP; Wirths O; Van de Berg WD; Lichtenthaler SF; Vehoff J; Steinbusch HW; Korr H; Beyreuther K; Multhaup G; Bayer TA; Schmitz C
Neurobiol Dis; 2003 Mar; 12(2):110-20. PubMed ID: 12667466
[TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking.
Omtri RS; Thompson KJ; Tang X; Gali CC; Panzenboeck U; Davidson MW; Kalari KR; Kandimalla KK
Neuroscience; 2018 Mar; 373():159-168. PubMed ID: 29337241
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of amyloid-like Aβ1-42 in AEL (autophagy-endosomal-lysosomal) vesicles: potential implications for plaque biogenesis.
Ling D; Magallanes M; Salvaterra PM
ASN Neuro; 2014 Mar; 6(2):. PubMed ID: 24521233
[TBL] [Abstract][Full Text] [Related]
17. Amyloid β peptide promotes lysosomal degradation of clusterin via sortilin in hippocampal primary neurons.
Wang Y; Qin X; Paudel HK
Neurobiol Dis; 2017 Jul; 103():78-88. PubMed ID: 28396259
[TBL] [Abstract][Full Text] [Related]
18. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
[TBL] [Abstract][Full Text] [Related]
19. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.
Tesseur I; Zou K; Esposito L; Bard F; Berber E; Can JV; Lin AH; Crews L; Tremblay P; Mathews P; Mucke L; Masliah E; Wyss-Coray T
J Clin Invest; 2006 Nov; 116(11):3060-9. PubMed ID: 17080199
[TBL] [Abstract][Full Text] [Related]
20. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
